Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New commercial varieties of oreille de chardon mushroom

07.05.2003


The Genetic and Microbiological research group at the Navarre Public University is working with the Agruset company from Rioja in the production of new commercial varieties of the fungus oreille de chardon mushroom (Pleurotus eryngii). The same group has developed 150 new varieties of the oyster mushroom (Pleurotus ostreatus), which enhances the productivity and quality of the varieties of this fungus which are currently being commercialised.



Mushroom agreeable to the palate

The Pleurotus eryngii mushroom, known in French as the oreille de chardon, is more agreeable to the palate and tastier than the Pleurotus ostreatus or the oyster mushroom, the variety which we most frequently find in the shops. The problem with the former is there is currently no standardised method for its cultivation or for the substrate in which it grows and, thus, its production is more expensive. A tray of P. ostreatus may cost 1.8€, whereas the eryngii will cost four times more.


A group of researchers from Navarre had a double objective. First, to standardise the growing conditions and substrate composition for the fungus and, secondly, to obtain new commercial varieties of this mushroom.

The standarisation phase for substrates is relatively short. The lengthiest process is the design of new varieties, because the most suitable strains in the available germoplasm have to be found, crossed amongst themselves and new molecular tools designed to enable directed crosses. It should be taken into account that these fungi are all the same in appearance, so some type of identification sign has to found.

I.D. card

Finally, the research includes typification and the drawing up of an identification card for the new varieties. One has to consider that the fungi propagate vegetatively, and so a company-improved piece there of may be picked and an identical sample achieved in its laboratory and, thus, all the investment carried out in research is in vain.

This card provides extra guarantees to companies like Agruset. It provides them with an ID card for its variety in such a way that it is assured, in the case of illegal commercial exploitation of the product, legal action can be undertaken.

Iñaki Casado Redin | Basque research
Further information:
http://www.unavarra.es

More articles from Life Sciences:

nachricht Human skin is an important source of ammonia emissions
27.05.2020 | Max-Planck-Institut für Chemie

nachricht Biotechnology: Triggered by light, a novel way to switch on an enzyme
27.05.2020 | Westfälische Wilhelms-Universität Münster

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

Im Focus: I-call - When microimplants communicate with each other / Innovation driver digitization - "Smart Health“

Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.

When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...

Im Focus: When predictions of theoretical chemists become reality

Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.

Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...

Im Focus: Rolling into the deep

Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.

A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

German-British Research project for even more climate protection in the rail industry

28.05.2020 | Transportation and Logistics

A special elemental magic

28.05.2020 | Physics and Astronomy

Skoltech scientists get a sneak peek of a key process in battery 'life'

28.05.2020 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>